The global rise in obesity and diabetes has led to a parallel increase in CKD and end-stage kidney disease. Metabolic alterations such as insulin ...

Based on this, this study retrospectively analyzes the clinical testing data of patients with diabetic nephropathy and those with simple diabetes mellitus to investigate the predictive value of ...

Argus Research analyst Jasper Hellweg maintained a Buy rating on Zoetis yesterday. The company’s shares closed yesterday at $118.26. According to TipRanks, Hellweg is a 4-star analyst with an average ...

Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing ...

My niece was diagnosed with birdshot chorioretinopathy. Can you please explain what this is, which treatments are involved, and what the typical prognoses are? — P.Z.

Heavy drinking on the occasional Saturday night — even if you don't drink at all for the rest of the month — may damage your liver more than previously understood.

Q4 2025 Management View CEO Yogesh Jashnani said 2025 was “a year of rebuilding and transformation,” citing added talent, new processes, a new go-to-market strategy, and “strategically exited our only ...

In a report released yesterday, Michael Ryskin from Bank of America Securities maintained a Hold rating on Zoetis, with a price target of $140.00. Ryskin covers the Healthcare sector, focusing on ...

“You’re on a chemotherapeutic and your oncologist may say that your dosage is X, while a nephrologist is telling you that the proximal tubules in your kidneys can’t handle it. You’re harming them.” ...

Add Yahoo as a preferred source to see more of our stories on Google. Despite multiple warnings from the Food and Drug Administration about its manufacturing processes, Nephron Pharmaceuticals, one of ...

Santander Corporate & Investment Banking announced that its U.S. broker-dealer, Santander US Capital Markets LLC, entered a strategic alliance with healthcare-focused Nephron Research LLC. This is ...

This alliance provides Nephron Research leverage to expand its industry-leading brand into new markets and services and deepen its existing reach with global institutional clients. NEW YORK, Oct. 1, ...